Arnold G Vulto Selected Research

Arnold G Vulto Research Topics

Disease

7	Neoplasms (Cancer) 06/2020 - 06/2002
5	Glycogen Storage Disease Type II (Pompe's Disease) 01/2024 - 04/2004
4	Hemorrhage 12/2016 - 06/2002
4	Pre-Eclampsia (Preeclampsia) 06/2015 - 10/2005
3	Rheumatoid Arthritis 01/2023 - 01/2017
3	Breast Neoplasms (Breast Cancer) 05/2021 - 11/2009
3	Asthma (Bronchial Asthma) 01/2016 - 03/2013
3	Heart Failure 10/2004 - 06/2002
2	Psoriatic Arthritis 01/2023 - 01/2021
2	Body Weight (Weight, Body) 05/2021 - 03/2010
2	Ulcerative Colitis 01/2021 - 01/2017
2	Crohn Disease (Crohn's Disease) 01/2021 - 01/2017
2	Ankylosing Spondylitis 01/2021 - 01/2017
2	Febrile Neutropenia 06/2020 - 05/2004
2	Hypertension (High Blood Pressure) 06/2020 - 06/2015
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 01/2017
2	Infections 01/2013 - 11/2003
2	Invasive Pulmonary Aspergillosis 05/2006 - 10/2005
1	Inflammation (Inflammations) 01/2024
1	Rheumatic Diseases (Rheumatism) 01/2023
1	Axial Spondyloarthritis 01/2023
1	Neuroinflammatory Diseases 12/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Neutropenia 06/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Malignant Mesothelioma 01/2018
1	Pulmonary Hypertension 03/2010
1	Anxiety Disorders (Anxiety Disorder) 04/2009
1	Drug-Related Side Effects and Adverse Reactions 04/2008
1	Adenocarcinoma 06/2007
1	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2007
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2006
1	Proteinuria 11/2006
1	Albuminuria 11/2006
1	Hyperkalemia 11/2006

Drug/Important Bio-Agent (IBA)

5	Biosimilar PharmaceuticalsIBA 05/2021 - 01/2017
5	Antihypertensive Agents (Antihypertensives)IBA 06/2020 - 10/2005
4	alpha-Glucosidases (Acid Maltase)IBA 01/2024 - 04/2004
4	AnticoagulantsIBA 10/2004 - 06/2002
3	AcidsIBA 01/2024 - 06/2022
3	GlycogenIBA 01/2024 - 04/2004
3	GlucosidasesIBA 12/2022 - 05/2004
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 03/2013
3	KetanserinIBA 06/2015 - 10/2005
3	CoumarinsIBA 10/2004 - 06/2002
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2004
2	EnzymesIBA 06/2022 - 12/2005
2	Trastuzumab (Herceptin)FDA Link 05/2021 - 01/2019
2	Nicardipine (Dagan)FDA LinkGeneric 06/2015 - 12/2005
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 11/2009 - 04/2009
2	Amphotericin B (Amphotericin)FDA LinkGeneric 05/2006 - 10/2005
2	coumarinIBA 10/2004 - 07/2004
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2024
1	ProteomeIBA 01/2024
1	Peptides (Polypeptides)IBA 01/2024
1	CalciumIBA 01/2024
1	CationsIBA 01/2024
1	Codon (Codons)IBA 01/2024
1	Phosphates (Orthophosphate)IBA 01/2024
1	Insulin-Like PeptidesIBA 01/2024
1	Mannose (D-Mannose)IBA 01/2024
1	Antirheumatic Agents (DMARD)IBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Amlodipine (Norvasc)FDA LinkGeneric 06/2020
1	Filgrastim (Neupogen)FDA Link 06/2020
1	pegfilgrastim (Neulasta)FDA Link 06/2020
1	TabletsIBA 06/2020
1	SolutionsIBA 06/2020
1	human ERBB2 proteinIBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	Infliximab (Remicade)FDA Link 01/2017
1	DihydralazineIBA 06/2015
1	Oseltamivir (Tamiflu)FDA Link 01/2013
1	Antiviral Agents (Antivirals)IBA 01/2013
1	Sildenafil Citrate (Viagra)FDA Link 03/2010
1	Tamoxifen FDA LinkGeneric 11/2009
1	4-hydroxy-N-desmethyltamoxifenIBA 11/2009
1	Antidepressive Agents (Antidepressants)IBA 04/2008
1	glycylproline (Gly-Pro)IBA 06/2007
1	hydroxide ionIBA 06/2007
1	arginylprolineIBA 06/2007
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 06/2007
1	Pentetic Acid (DTPA)FDA LinkGeneric 06/2007
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2007
1	NeurotensinIBA 06/2007
1	ProdrugsIBA 06/2007
1	Spironolactone (Aldactone)FDA LinkGeneric 11/2006
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2006
1	Angiotensin IIIBA 11/2006
1	Carbonic Anhydrase IXIBA 05/2006

Therapy/Procedure

6	Therapeutics 06/2022 - 07/2004
3	Enzyme Replacement Therapy 06/2022 - 04/2004
3	Drug Therapy (Chemotherapy) 06/2020 - 11/2002
1	Ambulatory Care (Outpatient Care) 01/2021
1	Biological Therapy 01/2019
1	Immunotherapy 01/2018
1	Extracorporeal Membrane Oxygenation 03/2010
1	Hematopoietic Stem Cell Transplantation 06/2007